In SURMOUNT-1, the largest tirzepatide obesity trial, participants taking 5 mg lost approximately 15 percent of baseline body weight over 72 weeks
Recommended Dosage: Take the recommended dosage as indicated on the product packaging or as directed by your healthcare provider
Clinically proven protection, wears under makeup, no white cast
A licensed, board-certified physician will determine your eligibility for InjectCos weight loss program incorporating semaglutide
Collectively, these findings suggest that tirzepatide may affect OSAS severity predominantly through metabolic and inflammatory improvement, with potential adjunctive neuromuscular contributions
Any licensed Canadian physician or nurse practitioner can prescribe any of the three brands, including walk-in clinicians